Publication details
Prohibition of the commercialisation of the human body and its (non-)observance in gamete donation programmes
| Title in English | Prohibition of the commercialisation of the human body and its (non-)observance in gamete donation programmes. |
|---|---|
| Authors | |
| Year of publication | 2023 |
| Type | Appeared in Conference without Proceedings |
| Citation | |
| Description | Human body parts such as organs, tissues, cells or blood are now commonly used in the treatment and therapy of various diseases and health problems. However, the problem is that there are not enough of them for these purposes. As a result, the need for sufficient motivation of potential donors is intensifying, which is being done by providing compensation and other benefits not only in the Czech Republic but also in other European countries. From an ethical and legal point of view, therefore, the question arises as to where the boundary between compensation and remuneration lies, the provision of which is contrary to the prohibition of the commercialisation of the human body and its parts, which is binding and generally enshrined in both international documents and European Union law. This issue becomes most problematic in relation to gamete donation programmes, in relation to which there are often only vague requirements at national level for the provision of adequate compensation.. This leads to the amount of compensation being set and used in practice as a promotional tool for reproductive clinics, which may of course also be pursuing their own (private or commercial) interests. Although the clinics are literally on the edge of the law, their control and possible sanction is very problematic under the current legal situation. |
| Related projects: |